Parafon Forte Dsc

Parafon Forte Dsc

Parafon Forte Dsc Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Serious (including fatal) hepatocellular toxicity has been reported rarely in patients receiving chlorzoxazone. The mechanism is unknown but appears to be idiosyncratic and unpredictable. Factors predisposing patients to this rare event are not known. Patients should be instructed to report early signs and/or symptoms of hepatotoxicity such as fever, rash, anorexia, nausea, vomiting, fatigue, right upper quadrant pain, dark urine, or jaundice. Chlorzoxazone should be discontinued immediately and a physician consulted if any of these signs or symptoms develop. Chlorzoxazone use should also be discontinued if a patient develops abnormal liver enzymes (e.g. AST, ALT, alkaline phosphatase and bilirubin).

The concomitant use of alcohol or other central nervous system depressants may have an additive effect.

 

The safe use of PARAFON FORTE DSC chlorzoxazone has not been established with respect to the possible adverse effects upon fetal development. Therefore, it should be used in women of childbearing potential only when, in the judgment of the physician, the potential benefits outweigh the possible risks.

 

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

PARAFON FORTE DSC chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Chlorzoxazone does not directly relax tense skeletal muscles in man.

 

History

There is currently no drug history available for this drug.

Other Information

Each caplet (capsule shaped tablet) contains:

Chlorzoxazone*500 mg

1

Inactive ingredients: FD&C Blue No. 1, microcrystalline cellulose, docusate sodium, lactose (hydrous), magnesium stearate, sodium benzoate, sodium starch glycolate, pregelatinized corn starch, D&C Yellow No. 10.

 

1 5-chlorobenzoxazolinone

Parafon Forte Dsc Manufacturers


  • Remedyrepack Inc.
    Parafon Forte Dsc (Chlorzoxazone) Tablet [Remedyrepack Inc. ]
  • Janssen Pharmaceuticals, Inc.
    Parafon Forte Dsc (Chlorzoxazone) Tablet [Janssen Pharmaceuticals, Inc.]
  • Remedyrepack Inc.
    Parafon Forte Dsc (Chlorzoxazone ) Tablet [Remedyrepack Inc. ]

Login To Your Free Account